PharmaCyte Biotech Inc (PMCB)
2.08
-0.05
(-2.35%)
USD |
NASDAQ |
May 23, 10:23
PharmaCyte Biotech Max Drawdown (5Y): 99.03% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.03% |
March 31, 2024 | 99.03% |
February 29, 2024 | 99.03% |
January 31, 2024 | 99.03% |
December 31, 2023 | 99.03% |
November 30, 2023 | 99.03% |
October 31, 2023 | 99.03% |
September 30, 2023 | 99.03% |
August 31, 2023 | 99.03% |
July 31, 2023 | 99.03% |
June 30, 2023 | 99.03% |
May 31, 2023 | 99.03% |
April 30, 2023 | 99.03% |
March 31, 2023 | 99.03% |
February 28, 2023 | 99.03% |
January 31, 2023 | 99.03% |
December 31, 2022 | 99.03% |
November 30, 2022 | 99.03% |
October 31, 2022 | 99.03% |
September 30, 2022 | 99.03% |
August 31, 2022 | 99.03% |
July 31, 2022 | 99.03% |
June 30, 2022 | 99.03% |
May 31, 2022 | 99.03% |
April 30, 2022 | 99.03% |
Date | Value |
---|---|
March 31, 2022 | 99.03% |
February 28, 2022 | 99.03% |
January 31, 2022 | 99.03% |
December 31, 2021 | 99.03% |
November 30, 2021 | 99.03% |
October 31, 2021 | 99.03% |
September 30, 2021 | 99.03% |
August 31, 2021 | 99.03% |
July 31, 2021 | 97.32% |
June 30, 2021 | 97.32% |
May 31, 2021 | 97.32% |
April 30, 2021 | 97.32% |
March 31, 2021 | 97.32% |
February 28, 2021 | 97.32% |
January 31, 2021 | 97.32% |
December 31, 2020 | 97.32% |
November 30, 2020 | 97.32% |
October 31, 2020 | 94.41% |
September 30, 2020 | 94.41% |
August 31, 2020 | 94.41% |
July 31, 2020 | 94.41% |
June 30, 2020 | 94.41% |
May 31, 2020 | 94.41% |
April 30, 2020 | 94.41% |
March 31, 2020 | 94.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.41%
Minimum
May 2019
99.03%
Maximum
Aug 2021
97.39%
Average
99.03%
Median
Aug 2021
Max Drawdown (5Y) Benchmarks
CEL-SCI Corp | 96.13% |
AIM ImmunoTech Inc | 99.76% |
IGC Pharma Inc | 97.77% |
NovaBay Pharmaceuticals Inc | 99.91% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -49.58 |
Beta (5Y) | -0.1323 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.1% |
Historical Sharpe Ratio (5Y) | -0.4399 |
Historical Sortino (5Y) | -0.9746 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.33% |